Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 2009

View Archived Issues

Letrozole monotherapy better than sequential treatment with tamoxifen in breast cancer patients

Celladon and Momentum Research complete enrollment in phase II study of Mydicar

Mitsubishi Tanabe Pharma reports results from second quarter 2009

FDA grants orphan drug designation to Delcath Systems' doxorubicin in HCC

Advanced Life Sciences reports results from nonhuman primate study of Restanza in anthrax

TransPharma Medical completes phase II ViaDerm-hPTH(1-34) trial in osteoporosis

Icagen reports topline results of phase IIa senicapoc study in allergic asthma

Catalyst Pharmaceutical Partners licenses rights to new GABA aminotransferase inhibitors

Cimzia approved for moderate to severe rheumatoid arthritis in Canada

Amgen claims chemokine CXCR3 receptor antagonists for asthma and other disorders

ACAT-2 inhibitors for the treatment of lipoprotein disorders disclosed by Kitasato Institute

Medivir selects cathepsin K inhibitor MIV-711 for development in bone diseases

Novavax reports results from phase II trial of trivalent VLP seasonal influenza vaccine

Lilly describes kappa opioid receptor antagonists for the treatment of ethanol use disorders

Adding colesevelam to a statin and ezetimibe lowers LDL-cholesterol in familial hypercholesterolemia

Novel prodrugs of antifungal agents in early development at Eisai

Vernalis presents Chk1 inhibitors for the treatment of cancer and other conditions

Novel DNA-damaging platinum complexes designed by Universitat de Barcelona

TRITON-TIMI 38 substudy suggests PPIs are safe with clopidogrel and prasugrel in ACS patients

Bristol-Myers Squibb acquires Medarex

First clinical results for BAY-60-4552 in biventricular heart failure reported

FDA requests additional clinical data from SkyePharma for Flutiform NDA in asthma

ON-TIME II analysis shows benefit of tirofiban in diabetic STEMI patients

Initiation of phase II clinical trial of ALX-0081 in patients undergoing PCI

Sinovac Biotech's H1N1 vaccine approved in SFDA expert meeting

Geron presents data to FDA in relation to clinical hold on IND for GRNOPC-1

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...